http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3a99ba2ddcfafd9b5a112359a8aba3a
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Puri |
| name | Raj K. Puri Raj K Puri |
| given-name | Raj K. Raj K |
| organization-name | Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD †Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892 From the Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, National Institutes of Health, Bethesda, MD. From the Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892. Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA The Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and ResearchFood and Drug Administration29 Lincoln Drive, NIH Building 29B, Room 2NN10BethesdaMaryland Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland. Centre for Biologics Evaluation and Research (CBER), U.S Food and Drug Administration, Silver Spring, MD, USA Division of Cellular and Gene Therapies, Tumor Vaccines and Biotechnology Branch, Center for Biologics and Evaluation Research, US Food and Drug Administration, Silver Spring, Maryland. 1Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Tumor Vaccines & Biotechnology Branch, Division of Cellular & Gene Therapies, Food & Drug Administration, Center for Biologics Evaluation & Research, Silver Spring, MD 20993, USA Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Bethesda, MD, 20892. From the Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapy, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD. Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapy, Center for Biologics Evaluation and Research, Food and Drug Administration Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, NIH Building 29B, Room 2NN10, 29 Lincoln Drive MSC 4555, Bethesda, MD 20892, USA Tumor Vaccines & Biotechnology Branch, Division of Cellular & Gene Therapies, Food & Drug Administration, Center for Biologics Evaluation & Research, NIH Building 29B, Room 2NN20, 29 Lincoln Drive, Bethesda, MD 20892, USA. Tumor Vaccines and Biotechnology Branch Division of Cellular and Gene Therapies, Office of Cellular, Tissue and Gene Therapy, Center for Biologics Evaluation and Research NIH Building 29B, Room 2E1229 Lincoln Drive Bethesda 20892 Maryland Authors' Affiliation: Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland Stem Cell Biology Unit, Laboratory of Neurosciences, National Institute on Aging Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, 20993, USA; Iovance Biotherapeutics, 825 Industrial Road, Suite 400, San Carlos, CA 94070, USA 1Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland and 2Gastroenterology Division, Yokohama City University Graduate School of Medicine, Yokohama, Japan 1Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration; §Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993 1Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapies ‡ Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892 Division of Cellular and Gene Therapies, Office of Tissues and Advanced Therapies, U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, Maryland. From the Department of Urology, State University of New York at Syracuse, Health Science Center, Syracuse, New York; the Department of Urology, Wayne State University School of Medicine, Detroit, Michigan; the Department of Surgery, Division of Neurosurgery, Milton S. Hershey Medical Center, Pennsylvania State University College of Medicine, Hershey, Pennsylvania; and the Laboratory of Molecular Biology, Division of Cancer Biology, Diagnosis and Centers, National Cancer Institute, and Laboratory of... Division of Cellular and Gene Therapies, Food and Drug Administration, Center for Biologics Evaluation and Research, Bethesda, Maryland. Center for Biologics Evaluation and Research 1Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville Pike, Rockville; Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, NIH Building 29B, 29 Lincoln Drive, Bethesda, MD 20892, USA a Division of Cellular and Gene Therapies Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA From the Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD. Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892. Tumor Vaccines and Biotechnology Branch Division of Cellular and Gene Therapies Center for Biologics Evaluation and Research Food and Drug Administration 29 Lincoln Drive MSC 4555 Bethesda, MD 20892, USA Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Center for Biologics and Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892. *Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, National Institutes of Health, Bethesda, MD 20892; and Tumor Vaccines and Biotechnology Branch Division of Cellular and Gene Therapies Center for Biologics Evaluation and Research Food and Drug Administration Silver Spring Maryland Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Tumor Vaccines and Biotechnology Branch (B.H.J., R.D., T.F., P.L., R.K.P.), Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892 *Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Bethesda, MD 20892; and Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892 Authors' Affiliations: 1Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Yoshidakonoe-cho, Sakyo-ku, Kyoto; 2Upstream Infinity, Inc., 1-7-8 Kaigan, Minato-ku, Tokyo, Japan; and 3Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, US food and Drug Administration, Bethesda, Maryland Cellular and Tissue Therapies Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA From the Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD; Laboratory of Neuroscience, National Institute on Aging, Baltimore, MD; Geron Corp, Menlo Park, CA; BresaGen Inc, Athens, GA; Department of Genetics, University of Georgia, Athens; and Department of Obstetrics and Gynecology, The Rambam Medical Center and Faculty of Medicine, Haifa, Israel. 1Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration; Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland Tumor Vaccines & Biotechnology Branch, Division of Cellular & Gene Therapies, Center for Biologics Evaluation & Research, US Food & Drug Administration, NIH Building 29B, Room 2NN20, Bethesda, MD 20892, USA. Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892 Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892. Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD 20852. |
Incoming Links
Total number of triples: 267.